|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào):G797838 |
| 產(chǎn)品名稱:GSK 2194069 |
| 產(chǎn)品CAS:1332331-08-4 |
| 規(guī)格含量:5mg |
| 產(chǎn)品價(jià)格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
G797838 |
| 名稱: |
GSK 2194069 |
| 別名: |
4-[4-(5-Benzofuranyl)phenyl]-5-[[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl]-2,4-dihydro-3H-1,2,4-triazol-3-one |
| CAS號(hào): |
1332331-08-4 |
| 分子式: |
C??H??N?O? |
| 分子量: |
428.48 |
| 種類: |
Standards; Enzyme Activators and Inhibitors; |
| 應(yīng)用: |
GSK 2194069 is a potent human fatty acid synthase (hFASN) inhibitor. |
| 參考文獻(xiàn) |
|
|
|
|